10-Year retrospective review of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) toxic doses in children < 6 years old

被引：0
|
作者：
Pham, Trang [1 ]
Ostrikova, Kim Vo [1 ]
Winter, Mark L. [1 ]
机构：
[1] Southeast Texas Poison Control Ctr, Galveston, TX USA
来源：
CLINICAL TOXICOLOGY | 2023年 / 61卷
关键词：
ACE; ARB;
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
343
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [41] Lithium toxicity following co-prescription of lithium and angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs)
    Ahmadi, Fatemeh
    Muanda, Flory Tsobo
    Garg, Amit
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 589 - 589
  • [42] Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
    Xu, Jiuyang
    Huang, Chaolin
    Fan, Guohui
    Liu, Zhibo
    Shang, Lianhan
    Zhou, Fei
    Wang, Yeming
    Yu, Jiapei
    Yang, Luning
    Xie, Ke
    Huang, Zhisheng
    Huang, Lixue
    Gu, Xiaoying
    Li, Hui
    Zhang, Yi
    Wang, Yimin
    Hayden, Frederick G.
    Horby, Peter W.
    Cao, Bin
    Wang, Chen
    FRONTIERS OF MEDICINE, 2020, 14 (05) : 601 - 612
  • [43] Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
    Dezsi, Csaba Andras
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (03) : 167 - 173
  • [44] Renin–angiotensin–aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    L. M. Ruilope
    Acta Diabetologica, 2005, 42 : s33 - s41
  • [45] Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
    Csaba András Dézsi
    American Journal of Cardiovascular Drugs, 2014, 14 : 167 - 173
  • [46] Angiotensin-converting Enzyme Inhibitors (ACE) And Angiotensin Receptor Blockers (ARB) Appear To Attenuate Stroke Risk Over Time In Patients With Left Ventricular Assist Devices
    Chung, Jae-Hoon
    Wright, Jonathan
    Boulous, Mark
    Dalmacy, Djhenne
    Smith, Sakima
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 609 - 609
  • [47] Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study
    Kumar, Pardeep
    Kumar, Vinod
    Murlidhar, Fnu
    Fatima, Aliya
    Jahangir, Maha
    Khalid, Dua
    Memon, Muhammad Khizar
    Memon, Sidra
    Kumar, Besham
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [48] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
    Baker, William L.
    Coleman, Craig I.
    Kluger, Jeffrey
    Reinhart, Kurt M.
    Talati, Ripple
    Quercia, Robert
    Phung, Olivia J.
    White, C. Michael
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (12) : 861 - U6
  • [49] Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
    Huang, Yunyu
    Zhou, Qiyun
    Haaijer-Ruskamp, Flora M.
    Postma, Maarten J.
    BMC NEPHROLOGY, 2014, 15
  • [50] Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
    Yunyu Huang
    Qiyun Zhou
    Flora M Haaijer-Ruskamp
    Maarten J Postma
    BMC Nephrology, 15
12345